TNFRSF8 and neoplasm: CD30 expression can be associated with a malignant phenotype, or reflect the recruitment of an inflammatory milieu that enhances tumor growth and survival.[18] One could argue that CD30 positivity in CM might be the result of MCs activation or allergy and not be related to CM oncogenesis.